Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Change in Accured Expenses (2021 - 2025)

Senti Biosciences has reported Change in Accured Expenses over the past 5 years, most recently at $251000.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 87.64% year-over-year to $251000.0; the TTM value through Dec 2025 reached $559000.0, up 183.31%, while the annual FY2025 figure was $559000.0, 183.31% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $251000.0 at Senti Biosciences, down from $1.5 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $2.0 million in Q4 2024 and troughed at -$2.9 million in Q1 2024.
  • A 5-year average of $136765.4 and a median of $36466.0 in 2021 define the central range for Change in Accured Expenses.
  • On a YoY basis, Change in Accured Expenses climbed as much as 68753.86% in 2022 and fell as far as 137551.36% in 2022.
  • Year by year, Change in Accured Expenses stood at $39520.0 in 2021, then surged by 1334.72% to $567000.0 in 2022, then skyrocketed by 237.04% to $1.9 million in 2023, then rose by 6.28% to $2.0 million in 2024, then crashed by 87.64% to $251000.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for SNTI at $251000.0 in Q4 2025, $1.5 million in Q3 2025, and -$48000.0 in Q2 2025.